Published in J Immunol on August 01, 2000
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev (2009) 3.65
Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol (2008) 1.43
Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol (2009) 1.39
Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol (2001) 1.35
Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol (2010) 1.19
Activation of GPR4 by acidosis increases endothelial cell adhesion through the cAMP/Epac pathway. PLoS One (2011) 1.17
Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A (2012) 1.01
Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction. Mol Cell Proteomics (2008) 1.00
Cytokine modulation of liver annexin 1 expression during experimental endotoxemia. Am J Pathol (2001) 0.99
Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists. Int J Mol Sci (2013) 0.98
Annexin A1 and the regulation of innate and adaptive immunity. Front Immunol (2012) 0.94
Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol (2003) 0.86
Group IVA cytosolic phospholipase A2 (cPLA2alpha) and integrin alphaIIbbeta3 reinforce each other's functions during alphaIIbbeta3 signaling in platelets. Blood (2008) 0.86
Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. Proteomics (2010) 0.85
Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms. Sci Rep (2014) 0.85
Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation model. J Immunol (2002) 0.84
Annexin peptide Ac2-26 suppresses TNFα-induced inflammatory responses via inhibition of Rac1-dependent NADPH oxidase in human endothelial cells. PLoS One (2013) 0.83
Regulation of annexin I in rheumatoid synovial cells by glucocorticoids and interleukin-1. Mediators Inflamm (2006) 0.83
Role and interactions of annexin A1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation. Br J Pharmacol (2013) 0.78
The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide. J Neuroinflammation (2016) 0.76
The advantageous role of annexin A1 in cardiovascular disease. Cell Adh Migr (2016) 0.75
The restorative role of annexin A1 at the blood-brain barrier. Fluids Barriers CNS (2016) 0.75
Annexin-1 Mediates Microglial Activation and Migration via the CK2 Pathway during Oxygen-Glucose Deprivation/Reperfusion. Int J Mol Sci (2016) 0.75
Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J (2005) 5.46
Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest (1978) 4.35
Molecular characterization of the human beta 3-adrenergic receptor. Science (1989) 4.13
Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci U S A (1977) 3.74
Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest (1980) 2.06
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol (2001) 1.98
Anti-phospholipase proteins. Prostaglandins (1984) 1.93
Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology (1999) 1.90
Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J Biol Chem (1987) 1.85
Transporting therapeutics across the blood-brain barrier. Mol Med Today (1996) 1.82
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol (2001) 1.75
The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat Struct Biol (1999) 1.72
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest (1997) 1.69
Rabbit platelet bactericidal protein. J Exp Med (1971) 1.63
Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest (1997) 1.62
Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci U S A (1987) 1.62
Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A (1998) 1.60
Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol (1989) 1.59
Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med (1983) 1.49
Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J Biol Chem (1978) 1.47
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res (1996) 1.43
Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J Clin Invest (1989) 1.42
Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med (2001) 1.41
Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest (1979) 1.40
Characterization and partial purification of 'renocortins': two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids. Br J Pharmacol (1983) 1.39
Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure (2000) 1.34
Effect of propranolol on platelet function. Blood (1977) 1.31
The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol (1993) 1.31
A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal Biochem (1989) 1.28
Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J Clin Invest (1982) 1.26
Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest (1977) 1.26
Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med (1997) 1.25
BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices (2013) 1.24
Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. J Clin Invest (1987) 1.20
Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ (1998) 1.20
Platelet-dependent generation of chemotactic activity in serum. J Exp Med (1973) 1.18
The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function. Circulation (1982) 1.18
Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim Biophys Acta (1982) 1.15
IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine (1998) 1.14
Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol (1999) 1.13
Involvement of glucocorticoid receptors in steroid-induced inhibition of prostaglandin secretion. J Biol Chem (1979) 1.12
Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila. J Clin Microbiol (1983) 1.12
Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E. J Immunol (1985) 1.12
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells. J Clin Invest (1981) 1.11
A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br J Pharmacol (1989) 1.11
Platelet activation--a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin. Nature (1986) 1.11
Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent. FEBS Lett (1987) 1.10
Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology (2000) 1.10
Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest (1981) 1.09
Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension (1983) 1.09
Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells. J Biol Chem (2001) 1.09
Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease. Lancet (1977) 1.09
Prostacyclin production by cultured endothelial cell monolayers exposed to step increases in shear stress. J Lab Clin Med (1985) 1.08
Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls. FASEB J (2009) 1.08
Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem (1992) 1.08
Further characterization of the glucocorticoid-induced antiphospholipase protein "renocortin". Biochem Biophys Res Commun (1983) 1.08
A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro. In Vitro Cell Dev Biol (1988) 1.07
Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro. Blood (1981) 1.07
Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands. Biol Cell (1987) 1.06
Expression of three human beta-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells. Eur J Biochem (1991) 1.05
New molecular and structural determinants involved in beta 2-adrenergic receptor desensitization and sequestration. Delineation using chimeric beta 3/beta 2-adrenergic receptors. J Biol Chem (1996) 1.04
Generation of a chemotactic lipid from a arachidonic acid by exposure to a superoxide-generating system. Inflammation (1980) 1.04
Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med (2009) 1.03
Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. J Biol Chem (1999) 1.02
Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler Thromb (1994) 1.02
The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids. Biochim Biophys Acta (1985) 1.01
Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. Free Radic Biol Med (1999) 1.00
Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J Biol Chem (1997) 1.00
Cytokine modulation of liver annexin 1 expression during experimental endotoxemia. Am J Pathol (2001) 0.99
Expression of two human beta-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein. Proc Natl Acad Sci U S A (1991) 0.98
Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia (2005) 0.98
Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells. FEBS Lett (1987) 0.98
Human complement in the arachidonic acid transformation pathway in platelets. J Exp Med (1981) 0.97
Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med (1998) 0.97
Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes. Br J Pharmacol (1995) 0.96
Metabolic activity of cholesteryl esters in aortic smooth muscle cells is altered by prostaglandins I2 and E2. J Lipid Res (1983) 0.96
Astrocyte-endothelial interaction: physiology and pathology. Neuropathol Appl Neurobiol (1992) 0.96
Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. Biochem Biophys Res Commun (1985) 0.96
Structural basis for functional diversity of beta 1-, beta 2- and beta 3-adrenergic receptors. Biochem Pharmacol (1991) 0.96
F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: effects of cyclic AMP and astrocytic factors. Brain Res (1997) 0.96
U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity. Br J Pharmacol (1998) 0.95
Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein. Proc Natl Acad Sci U S A (1994) 0.95
Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. Circulation (1985) 0.95
Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J (1998) 0.95
Identification of the Rochalimaea henselae 16S rRNA sequence in the liver of a French patient with bacillary peliosis hepatis. J Infect Dis (1992) 0.94
Cross-linking of brain endothelial intercellular adhesion molecule (ICAM)-1 induces association of ICAM-1 with detergent-insoluble cytoskeletal fraction. Arterioscler Thromb Vasc Biol (2001) 0.94
Inhibition of leukocyte migration by a staphylococcal factor. J Bacteriol (1969) 0.94
Quantification of static and dynamic supraglottic activity. J Speech Lang Hear Res (2001) 0.93
Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor. J Biol Chem (1994) 0.93
Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur J Biochem (1995) 0.93
In adrenocortical tissue, annexins II and VI are attached to clathrin coated vesicles in a calcium-independent manner. Biochim Biophys Acta (1998) 0.92
Differential effects of sex steroids on prostaglandin secretion by male and female cultured piglet endothelial cells. Prostaglandins (1983) 0.92
Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways. J Neurosci (1997) 0.92
Experimental cerebral ischemia produces platelet aggregates. Neurology (1979) 0.92
Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett (1998) 0.91
Recovery of homogeneous and functional beta 2-adrenergic receptors from extracellular baculovirus particles. Nat Biotechnol (1997) 0.91
Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease. Hepatology (1995) 0.91